Paracetamol is one of the most widely used medicines in pregnancy for managing pain and fever. In recent years, some studies have raised concerns about a possible link with conditions such as autism and ADHD in children. This has understandably caused worry for expectant mothers and healthcare professionals alike.
A new Trusted Advice statement from the Scottish Intercollegiate Guidelines Network (SIGN), supported by the Medicines and Healthcare products Regulatory Agency (MHRA), provides clear reassurance. After reviewing the available evidence, both organisations confirm that paracetamol remains the safest option during pregnancy when used correctly.
What the Evidence Shows
- No proven causal link: While some observational studies suggested small associations between paracetamol use and neurodevelopmental outcomes, the evidence does not prove cause and effect.
- Important to treat pain and fever: Untreated symptoms can be harmful for both mother and baby, so avoiding treatment is not recommended.
- Best practice remains unchanged: Use the lowest effective dose for the shortest duration possible.
Implications for Healthcare Professionals
Pharmacists and other healthcare providers should feel confident in continuing to recommend paracetamol as first-line treatment during pregnancy. Key roles include:
- Offering reassurance to women who may have seen conflicting information online.
- Advising on correct dose and duration, and checking for other paracetamol-containing products.
- Encouraging review with a GP or midwife if regular use is needed.
- Signposting to reliable patient resources such as UKTIS BUMPS leaflets for additional support.
Key Advice for Patients
- Paracetamol is safe to use in pregnancy when taken as directed.
- Always follow the instructions on the pack and avoid exceeding the maximum daily dose.
- Speak to your pharmacist, GP or midwife if you need paracetamol for more than a few days or if symptoms persist.
The Take-Home Message
Paracetamol remains the recommended option for pain and fever in pregnancy. With updated guidance now available, pharmacists and healthcare professionals can confidently support women to use it safely and appropriately.